Ulisse Biomed S.p.A. (BIT:UBM)
Italy flag Italy · Delayed Price · Currency is EUR
0.7600
+0.0100 (1.33%)
Apr 28, 2025, 11:42 AM CET

Ulisse Biomed Revenue

In the year 2024, Ulisse Biomed had annual revenue of 767.93K EUR with 1,059.87% growth. Ulisse Biomed had revenue of 397.07K in the half year ending December 31, 2024, with 431.07% growth.

Revenue
767.93K
Revenue Growth
+1,059.87%
P/S Ratio
23.91
Revenue / Employee
95.99K
Employees
10
Market Cap
18.36M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2024767.93K701.72K1,059.87%
Dec 31, 202366.21K-72.23K-52.17%
Dec 31, 2022138.44K-142.00K-50.64%
Dec 31, 2021280.44K-325.06K-53.68%
Dec 31, 2020605.50K594.63K5,469.84%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Recordati Industria Chimica e Farmaceutica 2.34B
DiaSorin 1.19B
Amplifon 2.41B
Philogen 77.65M
EL.En. 565.85M
Pharmanutra 116.15M
Garofalo Health Care 467.77M
Safilo Group 993.22M
Revenue Rankings